Article Details

AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way

Retrieved on: 2020-12-21 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way. View article details on hiswai:

Excerpt

Partners AstraZeneca and FibroGen had been hoping for a 2020 approval for their blockbuster-to-be anemia drug roxadustat in the U.S., but that's not ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up